title: Novel targets for the treatment of ameloblastoma.
authors.affiliation: Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Turku, Turku, Finland Turku University Hospital, Turku, Finland Department of Oral Diagnostic Sciences, Institute of Dentistry, University of Eastern Finland, Kuopio, Finland Department of Oral and Maxillofacial Diseases, Kuopio University Hospital, Kuopio, Finland krihei@utu.fi.
authors.forename: K
authors.initials: K
authors.lastname: Heikinheimo
authors.affiliation: Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland MediCity Research Laboratories, University of Turku, Turku, Finland Turku Doctoral Programme of Molecular Medicine, Turku, Finland.
authors.forename: K J
authors.initials: KJ
authors.lastname: Kurppa
authors.affiliation: Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland MediCity Research Laboratories, University of Turku, Turku, Finland Department of Oncology, Turku University Hospital, Turku, Finland.
authors.forename: K
authors.initials: K
authors.lastname: Elenius
mesh_terms: D000564:Ameloblastoma / Q000188:drug therapy* / Q000235:genetics; D053823:Hedgehog Proteins / Q000235:genetics; D006801:Humans; D020935:MAP Kinase Signaling System / Q000235:genetics; D058990:Molecular Targeted Therapy; D009154:Mutation / Q000235:genetics; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics
chemical_list: D053823:Hedgehog Proteins; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf
keywords: biological therapy; genetic markers; jaw neoplasms; mitogen-activated protein kinase kinases; mutation; odontogenic tumors